Broad-spectrum antiviral drug HSRx 431(TM) tests effective against Zika virus
HSRx expects to begin human trials early in 2017 and will seek accelerated drug approval from the US FDA
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.